[Form 4] Electromed, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Andrew Summers, a director of Electromed, Inc. (ELMD), reported multiple open-market sales of company common stock on September 10 and 11, 2025. The Form 4 shows sales of 39,378, 16,203, 6,576, 404 and 3,153 shares at weighted average prices between $23.6791 and $26.6246, with sale price ranges disclosed for each lot. Some holdings are reported as indirectly owned by investment vehicles (SVP Deal Fund I LP and Summers Value Fund LP), and the filing disclaims direct beneficial ownership except to the extent of pecuniary interest. One reported sale of 3,153 shares on 09/11/2025 reduced the reporting person’s indirect holding in a specified vehicle to 0 shares according to the form. The filing is signed by an attorney-in-fact on behalf of the reporting person.

Positive

• None.

Negative

• The reporting person executed multiple open-market sales on 09/10/2025 and 09/11/2025, including lots of 39,378, 16,203, 6,576, 404 and 3,153 shares at reported weighted-average prices between $23.6791 and $26.6246.
• A sale of 3,153 shares on 09/11/2025 is reported to have reduced the indirect holding in a specified vehicle to 0 shares per the form.
• Significant holdings are reported as indirectly owned by SVP Deal Fund I LP and Summers Value Fund LP, with the reporting person disclaiming direct beneficial ownership except to the extent of pecuniary interest.

Insights

Securities Analyst

TL;DR: Director executed multiple open-market sales across two days, disclosing weighted-average prices and indirect fund holdings.

The Form 4 documents routine open-market dispositions by a director rather than option exercises or derivative transactions. The filing provides granular weighted-average prices and price ranges for each lot sold on September 10 and 11, 2025, allowing precise traceability of transaction pricing. Several positions are held indirectly through investment funds for which the reporting person is affiliated; the filer expressly disclaims direct beneficial ownership except for pecuniary interest. From a trading-activity perspective, this is material disclosure of insider selling but contains no accompanying narrative about intent or company developments.

Corporate Governance Expert

TL;DR: Insider sales were disclosed properly with standard disclaimers regarding indirect fund ownership.

The Form 4 appears procedurally complete: it names the reporting person, states relationship to the issuer as a director, lists transaction dates, codes, share amounts, weighted-average prices and ownership after the transactions, and includes explanatory notes about fund ownership and disclaimers. The filing includes an attorney-in-fact signature which is common for timely reporting. The disclosures about indirect ownership and the express disclaimer follow customary governance practice and clarify the distinction between personal and fund-held positions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Summers Andrew

(Last) (First) (Middle)

500 SIXTH AVENUE NW

(Street)

NEW PRAGUE MN 56071

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		S		39,378	D	$23.6791(1)	26,336	I	By SVP Deal Fund I LP(2)
Common Stock	09/10/2025		S		16,203	D	$25.159(3)	10,133	I	By SPV Deal Fund I LP(2)
Common Stock	09/10/2025		S		6,576	D	$25.9443(4)	3,557	I	By SPV Deal Fund I LP(2)
Common Stock	09/10/2025		S		404	D	$26.6246(5)	3,153	I	By SVP Deal Fund I LP(2)
Common Stock	09/11/2025		S		3,153	D	$24.4214(6)	0	I	By SPV Deal Fund I LP(2)
Common Stock								9,000	D
Common Stock								270,267	I	By Summers Value Fund LP(7)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 39,378 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $23.52 to $24.51 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

2. Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

3. Reflects the weighted average price of 16,203 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $24.52 to $25.51 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Reflects the weighted average price of 6,576 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $25.515 to $26.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

5. Reflects the weighted average price of 404 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 10, 2025 with sale prices ranging from $26.525 to $26.635 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

6. Reflects the weighted average price of 3,153 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on September 11, 2025 with sale prices ranging from $24.39 to $24.46 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

7. Securities owned directly by Summers Value Fund LP ("Summers Value Fund"). Mr. Summers, as the Managing Member of each of Summers Value Partners GP LLC, the general partner of Summers ValueFund, and Summers Value Partners LLC ("Summers Value Partners"), the investment manager of Summers Value Fund, may be deemed to beneficially own the securities owned directly by Summers ValueFund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

	/s/ Joshua L. Colburn, Attorney-in-fact	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Andrew Summers report for ELMD on this Form 4?

The filing reports multiple open-market sales on 09/10/2025 and 09/11/2025 of common stock including lots of 39,378, 16,203, 6,576, 404 and 3,153 shares at weighted-average prices between $23.6791 and $26.6246.

Does the Form 4 show any change to indirect holdings in investment vehicles?

Yes. The Form 4 reports that certain shares are indirectly owned by SVP Deal Fund I LP and Summers Value Fund LP, and a reported sale on 09/11/2025 reduced one indirect holding to 0 shares as stated in the filing.

What relationship to Electromed does the reporting person have?

The reporting person, Andrew Summers, is listed as a Director of Electromed, Inc. (ELMD) on the Form 4.

Are the sale prices and ranges disclosed on the Form 4?

Yes. The filing discloses weighted-average prices for each lot and price ranges for the multiple transactions, and it offers to provide full information about the number of shares sold at each separate price upon request by the SEC staff, the issuer, or a security holder.

Who signed the Form 4 and when?

The Form 4 is signed by /s/ Joshua L. Colburn, Attorney-in-fact with a signature date of 09/12/2025 as shown on the filing.